Agreements and acquisitions keep Verfora ahead

21 January 2021 - Deborah Wilkes

Premium

New distribution agreements and acquisitions helped lift sales at Galenica’s Products & Brands business, which mainly consists of the Verfora consumer healthcare unit, by 9.4% to CHF112 million (USD126 million) in 2020.

Click tags below for more information on topics:

Galenica

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: